Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Synthetic double-stranded siRNA oligonucleotide directed against p53 mRNA

EU orphan designation number: EU/3/10/751   
Active ingredient: Synthetic double-stranded siRNA oligonucleotide directed against p53 mRNA
Indication: Prevention of delayed graft function after renal transplantation
Sponsor: ProductLife Limited
The Jeffrey's Building, St John's Innovation Park, Cowley Road, Cambridge CB4 0DS, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2010 Orphan Designation EMEA/OD/142/09 (2010)3834 of 09/06/2010
23/03/2011 Change of address of sponsor EMEA/OD/142/09
26/03/2012 Change of address of sponsor EMEA/OD/142/09
14/03/2013 Change name of sponsor